Sat.Apr 15, 2023 - Fri.Apr 21, 2023

article thumbnail

Tired of ‘dead end’ approach, herpes patients mobilize to demand government action

STAT

A medical student spoke emotionally about grappling with a diagnosis his classes told him little about. A young queer man took one test, got a different result on the next, and is now saving up the money needed for the most advanced diagnostics, which insurers rarely cover. A young woman tested positive, got little guidance from her doctor and found information on government sites that she interpreted as pushing abstinence.

363
363
article thumbnail

A CMO’s quest to tackle infectious diseases leads him to an eye condition that’s often overlooked

PharmaVoice

How an “international” childhood sent Dr. José Trevejo, Tarsus’s chief medical officer, on a mission to fight infectious diseases.

246
246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

‘We are working in an environment that is setting us up to fail’

The Pharmacist

If you go into a community pharmacy, it’s not hard to see the staff being pulled in different directions. Patients are waiting; prescriptions are piling up; delivery drivers need to head out. It’s no easier in other sectors of pharmacy, where most of us are dealing with limited support staff and an increasingly high workload. […] The post ‘We are working in an environment that is setting us up to fail’ appeared first on The Pharmacist.

article thumbnail

Merck to buy inflammatory disease drugmaker Prometheus for $10.8B

BioPharma Dive

The pharma has struck the sector’s second-largest buyout this year, announcing a deal for the developer of an inflammatory bowel disease treatment that’s shown promise in testing.

127
127
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Study: Black women should start breast cancer screening at age 42

STAT

For many years, there’s been considerable debate about the best age for women to initiate breast cancer screening.The U.S. Preventive Services Task Force recommends that women start getting screenings around age 50, while groups such as the American Cancer Society recommend screenings begin at an earlier age. Now a large new study suggests that if Black women begin screening for breast cancer at age 42, that could help lower racial disparities in breast cancer deaths.

345
345
article thumbnail

Conditions for worker burnout in biotech are ripe. Here’s how to beat it

PharmaVoice

One of the country’s leading burnout experts explains how companies can help keep high stress from becoming a high desire to leave the job.

246
246

More Trending

article thumbnail

Moderna, Merck data support claim of cancer vaccine’s promise

BioPharma Dive

Data presented at AACR suggest a personalized shot made with messenger RNA may amplify the effects of a widely prescribed cancer immunotherapy.

136
136
article thumbnail

Discrimination lawsuit against HHMI spotlights barriers faced by scientists with disabilities

STAT

University of Michigan pediatric neurologist Vivian Cheung made a name for herself studying rare genetic diseases, and in 2008 — when she was on the faculty at the University of Pennsylvania — was hired as a Howard Hughes Medical Institute investigator, an honor for which she received $1 million a year over the next 12 years to further her research.

316
316
article thumbnail

The 99 seconds that changed this CEO’s life

PharmaVoice

Peter Kirk’s marathon story of inspiration and perseverance.

264
264
article thumbnail

FDA approves allogeneic stem cell transplant therapy

European Pharmaceutical Review

“The approval of Omisirge is a significant development in hematopoietic stem cell transplantation” Omisirge ® (omidubicel-onlv), now US Food and Drug Administration (FDA) approved , is the first allogeneic stem cell transplant therapy to be given marketing authorisation based on results from a global, randomised Phase III clinical study. The treatment is indicated for patients 12 years and older with hematologic malignancies planned for umbilical cord blood transplantation, following myeloablati

111
111
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

J&J study data show dramatic benefit to multiple myeloma cell therapy

BioPharma Dive

A study abstract inadvertently posted online showed J&J and Legend’s therapy, Carvykti, reduced the risk of disease progression or death by more than 70% over standard drugs.

120
120
article thumbnail

FDA’s new plan to study opioids’ effectiveness faces resistance

STAT

The Food and Drug Administration’s latest plan to study whether opioids are effective as a chronic pain treatment is facing significant resistance from addiction and pain care experts. A planned clinical trial, doctors and researchers argued on Wednesday, would not yield significant new information about whether opioids are effective as long-term treatments for chronic pain.

258
258
article thumbnail

Letter 4: The Heart of a Manager

The Honest Apothecary

My Dear Nephew Simon, So great to hear from you again. I’m glad that you found some of the practical advice in the last letter to be helpful. Don’t be too discouraged by the negative cultures being created by other managers in different departments. Focus on your team for now. In time we will talk about how you expand your influence with other stakeholders around the organization.

107
107
article thumbnail

Merck agrees to acquire Prometheus Biosciences for $10.8bn

Pharmaceutical Technology

Merck has signed a definitive agreement to buy clinical-stage biotechnology firm Prometheus Biosciences for $10.8bn, strengthening its immunology pipeline. The company will buy all of Prometheus Biosciences’ outstanding shares for $200 a share through a subsidiary. Prometheus Biosciences uses precision medicine to discover, develop and commercialise new therapeutic and companion diagnostic products to treat immune-mediated diseases.

Immunity 105
article thumbnail

Startup Abdera raises $110M to fuel radiopharmaceutical research

BioPharma Dive

The company, which previously raised $32 million in Series A funding, joins a growing list of new startups working to develop targeted radiation treatments.

116
116
article thumbnail

CDC advisory panel backs changes to Covid vaccination policy

STAT

An expert panel that advises the Centers for Disease Control and Prevention on vaccination policy informally endorsed a plan Wednesday to offer an additional Covid-19 booster shot to people 65 and older as well as people who are immunocompromised, and to simplify the Covid vaccine schedule. The Advisory Committee on Immunization Practices was not asked to vote on the changes , announced Tuesday by the Food and Drug Administration.

Vaccines 258
article thumbnail

Wes Streeting: ‘We could do a lot more with community pharmacy’

The Pharmacist

Shadow health secretary Wes Streeting has suggested that community pharmacy could play ‘a really big role’ in his vision of ‘neighbourhood’ healthcare. Speaking at an event hosted by healthcare thinktank The King’s Fund today, the Labour health secretary outlined how he thought primary care could be reformed to make it ‘fit for the future’. He […] The post Wes Streeting: ‘We could do a lot more with community pharmacy’ appeared first on The Pharmacist.

article thumbnail

J&J Launches $50M Multiple Sclerosis Collaboration with Pipeline Therapeutics

PharmExec

J&J's Janssen Pharmaceutica NV collaborates with Pipeline Therapeutics in a $50 million licensing deal for oral MS drug PIPE-307, with potential earnings of up to $1 billion for Pipeline.

103
103
article thumbnail

Merck’s latest deal turns up the spotlight on immune system drugmakers

BioPharma Dive

The buyout of Prometheus highlights pharmaceutical companies’ intense interest in medicines targeting inflammatory diseases, according to analysts.

Immunity 114
article thumbnail

In a town plagued by an environmental crisis, a local abortion debate consumes public attention

STAT

BRISTOL, Tenn. — Zoe Poplin cupped her hands around her 17-month-old’s head, as if her palms over his ears could protect him. “I’m worried about him,” she said. She stroked baby Ezra’s back. “Because when they’re little, you know, their little cells are splitting real fast, and he’s growing and all it takes is one misreading, and he could end up with childhood cancer.

article thumbnail

Pharma á la carte – 4/22/23

The Honest Apothecary

Here I share some of the latest news, articles, editorials, or blog posts that fall generally under the theme of Pharma or healthcare. I might throw in a something off-topic from time to time which I found while wandering throughout the endless hallways and corridors of the internet. All article shared will be free to read and not locked behind an annoying paywall.

article thumbnail

Moderna and IBM to explore quantum computing and AI for mRNA research

Pharmaceutical Technology

Moderna has signed an agreement with IBM to explore quantum computing and generative artificial intelligence (AI) for advancing and expediting its mRNA research. Moderna will gain access to IBM’s quantum computing systems, an emerging technology that harnesses quantum mechanics for solving complex problems that cannot be handled efficiently by classical computers.

98
article thumbnail

GSK to buy Bellus Health and its chronic cough drug for $2B

BioPharma Dive

The acquisition gives GSK a competitor to a similar drug being developed by Merck for the condition, which the companies estimate affects millions of people in the U.S.

106
106
article thumbnail

Suspected suicide attempts surged among youth during pandemic, study shows

STAT

The rate of suspected suicide attempts by self-poisoning among children and adults aged 10 to 19 in the U.S. rose by 30% in 2021 compared with pre-pandemic rates, according to a new study published Thursday. The largest surge was among the youngest in that age group — the rate rose 73% for 10- to 12-year-olds and about 49% for 13- to 15-year-olds, compared to 11% for 16- to 19-year-olds.

255
255
article thumbnail

How meaningful music can help people with dementia

The Pharmacist

Pharmacies have been instrumental in helping people with dementia recover precious memories through music that is meaningful for them, says Rebecca Kennedy, head of communities at the charity Playlist for Life From improving wellbeing to strengthening relationships with families and loved ones, the benefits of music for people living with dementia are multiple.

98
article thumbnail

Incyte receives EC approval for Opzelura to treat non-segmental vitiligo

Pharmaceutical Technology

Incyte has received marketing authorisation from the European Commission for Opzelura (ruxolitinib) cream 15mg/g to treat non-segmental vitiligo with facial involvement in adults and in adolescents aged 12 years and above. Opzelura is the first and only approved treatment across the European Union (EU) aimed at achieving repigmentation in the targeted patients.

98
article thumbnail

Key Facts Everyone Should Know About Parkinson’s Disease

Putting Patients First Blog

Key Facts Everyone Should Know About Parkinson’s Disease April 17, 2023 By: John Lehr, President & Chief Executive Officer, Parkinson’s Foundation When most people think of Parkinson’s disease (PD), they think of a tremor or difficulty moving. However, Parkinson’s affects more than just movement. Symptoms, such as trouble sleeping and loss of smell, known as non-movement symptoms, often occur before a tremor.

98
article thumbnail

Key senators make a big pivot on bipartisan insulin cost proposal

STAT

WASHINGTON — Amid a scramble to assemble a health care policy package in the Senate, a pair of key senators have significantly changed a proposal to cap insulin costs. The new legislation by Senate Diabetes Caucus co-chairs Sens. Jeanne Shaheen (D-N.H.) and Susan Collins (R-Maine) would cap insured patients’ insulin costs at $35 per month for at least one insulin of each type and dosage form, and require pharmacy benefit managers to pass through rebates they collect from insulin ma

Dosage 246
article thumbnail

Do I Need To Memorize Clinical Trials For the BCPS Exam?

Med Ed 101

I get a lot of questions on all the board certification exams and while this recent question was specific to the BCPS exam, my answer applies to all of the BPS exams, the NAPLEX exam, and the BCMTMS exam. I cover many of those frequently asked questions about the 2023 board exams in the posts […] The post Do I Need To Memorize Clinical Trials For the BCPS Exam?

98
article thumbnail

FDA pushes Daiichi Sankyo’s quizartinib approval date by three months

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has pushed quizartinib’s Prescription Drug User Fee Act (PDUFA) date in newly diagnosed FLT3-ITD positive acute myeloid leukemia (AML) for the review of updates of Risk Evaluation and Mitigation Strategies (REMS) included in the application. The PDUFA date was extended by three months to July 24, based on an April 20 company announcement.

article thumbnail

Pharmacy First research alert ‘not a guarantee or commitment’

The Pharmacist

An online post that appeared to suggest that a Pharmacy First service could commence from late October this year should not be interpreted as an announcement of the service, government and pharmacy leaders have advised. A notice shared on the National Institute for Health and Care Research (NIHR) website last month seemed to suggest that […] The post Pharmacy First research alert ‘not a guarantee or commitment’ appeared first on The Pharmacist.

97
article thumbnail

FDA says older adults and the immunocompromised may get a spring booster dose of Covid vaccine

STAT

People ages 65 and older and those who are immunocompromised will be allowed to receive an additional dose of Covid-19 vaccine this spring if they wish, the Food and Drug Administration announced Tuesday. In authorizing another dose for people in these demographics, the agency is following in the footsteps of Canada and the United Kingdom, which earlier announced that older adults, adults who live in care facilities, and people who are immunocompromised would have access to an additional booster

Vaccines 246
article thumbnail

Beta-Blocker Interactions and CYP Enzymes – Free Table

Med Ed 101

Beta-blockers are a class of medication that is frequently used for cardiac and cardiovascular purposes. Selectivity and evidence of benefit often guide selection, but one thing that may get overlooked is beta-blocker interactions in relation to CYP enzymes. Not all beta-blockers interact with CYP enzymes and those that don’t always follow a pattern.

97
article thumbnail

Hasten Biopharmaceutic raises $315m for pipeline assets development

Pharmaceutical Technology

Chinese firm Hasten Biopharmaceutic has raised $315m for business development of its pipeline assets in a financing round co-led by Singapore-based CBC Group and Abu Dhabi sovereign wealth fund Mubadala Investment, The funding round was supported by additional institutional investors. Hasten will also use the proceeds from the round to fund future acquisitions.

98
article thumbnail

Pharma á la carte 04/20/23

The Honest Apothecary

A gathering of some interesting Pharma and healthcare related news from around the web for Thursday, April 20, 2023 : What Health Systems Could Learn from Starbucks “ Sara Vaezy: Companies like Starbucks and Amazon have done really well at connecting buyers and sellers. In our case, it’s connecting the clinician and the patient, or the system to the consumer with things such as content, information, tools and services.” Reminds of the classic book by Fred Lee, If Disney Ran You